Question 1

What is Martin Shkreli?

Accepted Answer

Martin Shkreli is a Company.

Question 2

How often does Martin Shkreli appear in global news?

Accepted Answer

Tracked across 3 news events drawn from 19 articles.

Question 3

When was Martin Shkreli first tracked by Ergen?

Accepted Answer

First tracked on Apr 13, 2026.

Question 4

When was Martin Shkreli last mentioned in news?

Accepted Answer

Last active on Jul 11, 2026.

Question 5

What is Martin Shkreli's current news sentiment?

Accepted Answer

Aggregate sentiment score: 23 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Martin Shkreli in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 3 events.

Question 7

What is the most recent event involving Martin Shkreli?

Accepted Answer

FDA Approves Travere's FILSPARI for FSGS (Apr 13, 2026, 6 articles).

Question 8

How did the "FDA Approves Travere's FILSPARI for FSGS" event impact Martin Shkreli?

Accepted Answer

Martin Shkreli received full FDA approval for FILSPARI for FSGS, expanding its market reach and potential revenue. This approval is a significant positive development for the company.

Question 9

How did the "Travere Therapeutics grants employee equity" event impact Martin Shkreli?

Accepted Answer

Martin Shkreli granted inducement equity grants to six new employees, which is a positive move for employee retention and recruitment.

Question 10

How did the "Vera Therapeutics FDA Approval TRUTAKNA" event impact Martin Shkreli?

Accepted Answer

Martin Shkreli' Filspari faces new competition from TRUTAKNA in the IgAN market.

Question 11

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.